• SENSEX 81,425.15
    323.83 (+0.40%)
  • BANKNIFTY 54,536.00
    319.90 (+0.59%)
  • N S D L
    1,301.00 880.00(%)
  • Vikram Solar
    407.85 407.85(%)
  • Kotak Mah. Bank
    1,990.00 2,301.55(%)
  • Avanti Feeds
    767.45 965.00(%)
  • Waaree Energies
    3,501.00 3,740.75(%)
  • MIC Electronics
    78.02 114.74(%)
  • Netweb Technol.
    3,217.95 3,312.00(%)
  • Bharat Electron
    389.00 435.95(%)
  • ICICI Bank
    1,416.35 1,494.10(%)
  • Timken India
    3,030.00 3,955.10(%)
  • TCS
    3,122.00 4,548.00(%)
  • Maruti Suzuki
    15,077.60 10,725.00(%)
  • Oracle Fin.Serv.
    9,299.00 13,203.60(%)
  • One Mobikwik
    299.35 218.85(%)
  • Infosys
    1,534.50 2,006.80(%)
  • Mamata Machinery
    492.00 649.00(%)
  • Vodafone Idea
    7.50 13.75(%)
  • M & M
    3,592.15 2,360.45(%)
  • Reliance Industr
    1,388.65 1,551.00(%)
  • Welspun Living
    128.25 188.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natco Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco
  • BSE Code : 4684.0
  • ISIN : INE987B01026
844.25 3 (0.36%)
  • As on 11 Sep 2025 (EOD)

  • Today’s Low

    841.80

  • Today’s High

    863.60

  • Open

    848.10

  • Perv Close

    841.25

  • 52W Low

    726.80

  • 52W High

    1,639.00

Key Indicators

  • P/E(TTM)

    9.02

  • Mar.Cap (₹Cr.)

    15,121.35

  • Div & Yield %

    0.71

  • Book Value(₹)

    409.46

  • Debt-Equity Ratio

    0.36

  • AGM Date

    10-Sep-2025

  • EPS

    93.70

  • P/E Ratio

    9.02

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    15,121.35

  • RONW (%)

    25.88

  • ROCE (%)

    29.63

Score Board

  • Equity (₹ in Cr.)

    35.82

  • BV (₹)

    409.50

  • Sales( ₹ in Cr.)

    4,094.50

  • NP (in Cr.)

    1,778.18

  • NP Var(%)

    36.0

  • Div%

    300.0

  • CPS (₹)

    111.60

  • EPS (₹)

    99.30

  • Traded Value (₹ in Lakhs)

    15,138.37

  • 52 Week High

    1,639.00

  • 52 Week Low

    726.80

  • Price BSE

    845.0

  • Price NSE

    844.00

  • Market Capital( in Cr.)

    15,138.37

  • P/C Ratio

    7.60

  • P/E Ratio

    8.50

  • Price Vs.BV

    99.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20
Other Income 321.30 104.70 85.50 94.60 101.10 123.80
Stock Adjustments -11.60 -17.20 -34.60 5.50 46.90 55.90
Total Income 4,404.20 3,656.40 2,401.90 1,867.90 1,801.50 1,969.90
EXPENDITURE :            
Raw Materials 581.70 557.30 495.10 540.10 546.90 452.90
Power and Fuel Cost 93.10 88.90 81.90 76.40 59.40 62.40
Employee Cost 515.30 454.90 425.70 410.10 380.00 356.10
Other Manufacturing Expenses 217.70 179.80 150.30 148.70 114.30 134.70
Selling and Administration Expenses 444.10 483.70 290.70 309.10 140.30 202.30
Miscellaneous Expenses 86.70 150.10 28.00 75.90 41.90 59.70
Employee Benefit Expenses 515.30 454.90 425.70 410.10 380.00 356.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,938.60 1,914.70 1,471.70 1,560.30 1,282.80 1,268.10
Operating Profit 2,465.60 1,741.70 930.20 307.60 518.70 701.80
Interest 19.60 14.50 8.60 13.30 11.30 20.60
Gross Profit 2,446.00 1,727.20 921.60 294.30 507.40 681.20
Depreciation 220.00 171.90 150.90 138.40 115.20 98.10
Profit Before Tax 2,226.00 1,555.30 770.70 155.90 392.20 583.10
Current Tax 407.50 284.80 133.10 32.50 93.30 129.10
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -31.90 -36.10 0.50 -15.70 -10.60 -20.50
Reported Net Profit 1,850.40 1,306.60 637.10 139.10 309.50 474.50
Extraordinary Items 72.22 -2.12 14.71 33.80 24.39 12.69
Adjusted Net Profit 1,778.18 1,308.72 622.39 105.30 285.11 461.81
Adjustment below Net Profit 3.00 -44.70 -1.00 0.40 2.20 -31.40
P & L Balance brought forward 4,226.30 3,134.60 2,587.10 2,520.50 2,322.50 2,006.80
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 107.50 170.20 88.60 72.90 113.90 127.40
P & L Balance carried down 5,972.20 4,226.30 3,134.60 2,587.10 2,520.30 2,322.50
Dividend 0.00 170.20 100.40 82.10 113.90 127.40
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 300.00 475.00 275.00 225.00 262.50 337.50
Dividend Per Share(Rs) 6.00 9.50 5.50 4.50 5.25 6.75
Earnings Per Share-Unit Curr 103.37 72.99 34.91 7.62 16.96 26.07
Earnings Per Share(Adj)-Unit Curr 103.37 72.99 34.91 7.62 16.96 26.07
Book Value 409.72 312.42 257.64 229.69 224.17 212.61
Book Value(Adj)-Unit Curr 409.72 312.42 257.64 229.69 224.17 212.61

Shareholding Pattern

  • Promoter Group

    49.56%

  • Public Share Holding

    50.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 746,910 746,910.00 746,910 746,910
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 746,910 0.42 746,910 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 33,070,070 18.46 33,070,070 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,267,145 28.07 50,267,145 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 4,686,150 2.62 4,686,150 4
Others 0 0.00 0 0
Sub Total 88,023,365 49.14 88,023,365 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 864 0.00 864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 65 0.00 65 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,786,067 15.51 27,786,067 239
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,137,761 3.43 6,137,761 12
Mutual Funds / UTI 3,787,591 2.11 3,787,591 47
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 493,838 0.28 493,838 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,206,186 21.33 38,206,186 317
2] Non Institution
Bodies Corporate 3,365,052 1.88 3,361,252 1,138
Clearing Members 3,323 0.00 3,323 8
Directors of their Relatives 120,023 0.07 120,023 10
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,571,775 1.44 2,570,775 9,666
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,984,785 3.34 5,984,785 18
Individuals holding nominal share capital up to Rs. 1 lakh 39,182,261 21.88 38,810,431 418,245
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,001 0.00 2,001 7
Others 904,189 0.50 904,189 3
Sub Total 52,133,409 29.11 51,756,779 429,095
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 179,109,870 100.00 178,733,240 429,434

Company Background

Natco Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco Pharma Ltd
  • BSE Code : 4684.0
  • ISIN : INE987B01026

  • Incorporation Year

    1981

  • Registered Office

    Natco House
    Road No 2 Banjara Hills, Hyderabad,
    Telangana-500033

  • Telephone

    91-040-23547532

  • FAX

    91-040-23548243

  • Chairman

    V C Nannapaneni

  • Managing Director

    V C Nannapaneni

  • Company Secretary

    Venkat Ramesh

  • Auditor

    B S R & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Natco Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natco Pharma 845.20 4,415.80 4,094.50 9.02 32.75
Abbott India 31,295.70 6,684.73 6,409.15 45.79 44.95
Astrazeneca Phar 8,984.60 1,756.92 1,716.29 122.51 32.94
P & G Health Ltd 6,331.90 944.52 934.17 34.97 40.23
Glaxosmi. Pharma 2,833.60 3,866.05 3,723.49 50.95 58.72
Cipla 1,563.70 20,029.57 19,044.85 23.37 21.40
Amrutanjan Healt 754.60 469.50 451.82 40.01 21.89
Guj. Themis Bio. 378.20 152.47 150.80 92.47 27.21
Fermenta Biotec. 351.85 442.21 430.53 11.67 17.61
Bliss GVS Pharma 152.65 703.42 667.20 22.82 9.16
Ambalal Sarabhai 31.89 19.33 4.04 16.70 2.10